Abstract:AIM: To clone and characterize novel genes that might be involved in hepatocellular carcinoma. METHODS: An EST fragment differentially expressed between hepatocellular carcinoma (HCC) and its adjacent nontumorous liver tissues had been doned using suppression subtractive hybridization (SSH). With this approach, we identified a novel EST that consisted of 447bp. In order to gain its full-length cDNA fragment, two gene-specific primers were designed for 3′-rapid amplification of cDNA end RACE. One HCC cell line, HepG2, was maintained in the RPMI1640 media and recommended culture conditions. Total RNA was extracted from HepG2 by the SV Total RNA Isolation System (Promega). PACE reactions were prepared using the SMART™ RACE cDNA amplification kit (Clontech). Initial amplification was carried out with gene-specific primer 3′GSP2(5′-CGCATAGT ACCAGTATCGACAA AGG-3′), followed by nested PCR using gene-specific primer 3′NGSP2(5′-TCCACATTACGGACCCGACGGATT- 3′). These amplified cDNA fragments obtained from RACE were subcloned into the PMD18-T vector (TaKaRa) and sequenced by ABI PRISM377 DNA sequencer. Basic local aligment search tools were carried out using BLASTN and dbEST and nr database. Northern blot was applied to detect the expression of these cDNA fragments between HCC and its adjacent nontumorous liver tissues. A total of 3 liver specimens were collected from the Southwest Hospital of Chongqing in China. The final diagnosis of HCC was confirmed by histological examination. Total RNA was extracted from either HCC or its adjacent nontumorous liver tissues in the same way. These cDNA fragments were excised from the PMD18-T vector, purified and 32P-labeled as cDNA probes using the random primed labeling method. Northern blot was prepared by using the ExpressHyb™ hybridization solution (Clontech) according to the protocol provided by the manufacturer. Combination of Northern blot and virtual Northern (http://www.ncbi.nlm.nih.gov/SAGE) (series analysis of gene expression, SAGE), expression of these cDNA fragments in multiple carcinoma and normal tissues were analyzed. RESULTS: Five EST fragments (694 447-3, 724 447-3, 697 447-3, 711 447-3, 692 447-3) were cloned, including two EST fragments with ploy (A) tail (694 447-3, 724 447-3). Compared with ESTs in GeneBank, the two EST fragments with ploy (A) tail represented novel genes with a common sequence. Five EST fragments accession numbers in Genebank were CK730344, CK730345, CK730346, CK730347, CK730348, respectively. Northern blot revealed that 694 447-3, 724 447-3 presented higher expression in HCC than that in its adjacent nontumorous liver tissues. Virtual Northern blot (SAGE) revealed that 694 447-3, 724 447-3 presented higher expression in multiple cancers that contained in brain, colon, breast, lung and stomach than that in their normal tissues. CONCLUSION: Two novel human hepatocellular carcinoma-associated cDNA fragments are identified. RACE technique is a rapid and effective method for seeking for disease related genes in specific tissues.

Screening and identification of genes transactivated by C1 protein by microarray assay

Screening and cloning of target genes transactivated by human gene C1 encoding protein 1 interacting with HBV core antigen using suppression subtractive hybridization technique

Genes Encoding Pir51, Beclin 1, RbAp48 and Aldolase B Are Up or Down-Regulated in Human Primary Hepatocellular Carcinoma.

Rapid cloning and expression of hepatocellular carcinoma associated cDNA fragments

Genes transactivated by hepatitis C virus core protein, a microarray assay.

Primary Study of the Function of a Novel Gene BC047440 Highly Expressed in Human Hepatocellular Carcinoma

Screening of Genes Differentially Expressed in HepG2 Cells Transfected with the Splice 512 of Gene 2transactivated by Hepatitis C Virus Nonstructural Protein 5A (NS5ATP2-512) Using Cdna Microarray

Gene expression profile of HepG2 cell transfected with a novel gene C-12 coding for HBcAg binding protein

Screening and Identification of Interacting Proteins with Hepatitis B Virus Core Protein in Leukocytes and Cloning of New Gene C1

Identification and Characterization of Gene 10 Transactivated by Hepatitis B Virus X Protein with DNA Microarray Assay

Cloning and identification of human gene 2 transactivated by nonstructural protein 3 of hepatitis C virus

Transactivating Effect of Hepatitis C Virus Core Protein: A Suppression Subtractive Hybridization Study

Screening and Cloning of the Target Genes Up-Regulated by Human Gene 13 Transactivated by Nonstructural Protein 5A of Hepatitis C Virus Using Suppression Subtractive Hybridization Technique

Identification of hepatocellular carcinoma antigens by serological analysis of recombinant cDNA expression library and detection of hcct-19 expression in human tissues and cell lines

Screening of Key Molecules of HAb18G/CD147 Signal Transduction Pathway in Human Hepatoma Cells

Cloning and identification of human gene 5 transactivated by nonstructural protein 5A of hepatitis C virus

[Differential Expression of Genes Related to Transcription in Cultured Hepatoma Cells with Intact Genome of Hepatitis C Virus].

Genes trans-regulated by a novel hepatitis B virus preS2 antigen binding protein S2-29 by cDNA microarray

[A Cdna Microarray Study of the Differential Expression of Genes in Signal Transduction Pathway During Hepatocarcinogenesis in Tree Shrews].

Screening and identification of genes trans-regulated by a novel HBeAg binding protein E-36 with cDNA microarrayassay

High-throughput sequencing-based analysis of gene expression of hepatitis B virus infection-associated human hepatocellular carcinoma